These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3424223)

  • 1. Monitoring for multiple malformations in the detection of epidemics of birth defects.
    Khoury MJ; Adams MM; Rhodes P; Erickson JD
    Teratology; 1987 Dec; 36(3):345-53. PubMed ID: 3424223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.
    Khoury MJ; Becerra JE; Cordero JF; Erickson JD
    Pediatrics; 1989 Oct; 84(4):658-65. PubMed ID: 2674881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring for new multiple congenital anomalies in the search for human teratogens.
    Khoury MJ; Botto L; Waters GD; Mastroiacovo P; Castilla E; Erickson JD
    Am J Med Genet; 1993 Jun; 46(4):460-6. PubMed ID: 8357024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring congenital rubella embryopathy.
    Rittler M; López-Camelo J; Castilla EE
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):939-43. PubMed ID: 15558544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide, a current teratogen in South America.
    Castilla EE; Ashton-Prolla P; Barreda-Mejia E; Brunoni D; Cavalcanti DP; Correa-Neto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; Lopez-Camelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; Pina-Neto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sánchez O; Schüler L
    Teratology; 1996 Dec; 54(6):273-7. PubMed ID: 9098920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and trends of multiple congenital anomalies in birth defects surveillance systems.
    Khoury MJ; Waters GD; Erickson JD
    Teratology; 1991 Jul; 44(1):57-64. PubMed ID: 1957264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance.
    Lynberg MC; Khoury MJ; Lammer EJ; Waller KO; Cordero JF; Erickson JD
    Teratology; 1990 Nov; 42(5):513-9. PubMed ID: 2278026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogen update: clinical aspects of thalidomide embryopathy--a continuing preoccupation.
    Newman CG
    Teratology; 1985 Aug; 32(1):133-44. PubMed ID: 4035587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring for congenital malformations.
    Holtzman NA; Khoury MJ
    Annu Rev Public Health; 1986; 7():237-66. PubMed ID: 3521645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An epidemiological investigation of anotia and microtia in China during 1988-1992].
    Zhu J; Wang Y; Liang J; Zhou G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 35(1):62-5. PubMed ID: 12768695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the ability of birth defects monitoring to detect new teratogens.
    Khoury MJ; Holtzman NA
    Am J Epidemiol; 1987 Jul; 126(1):136-43. PubMed ID: 3109235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth defects caused by isotretinoin--New Jersey.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Mar; 37(11):171-2, 177. PubMed ID: 3126387
    [No Abstract]   [Full Text] [Related]  

  • 13. The return of thalidomide: are birth defects surveillance systems ready?
    Yang Q; Khoury MJ; James LM; Olney RS; Paulozzi LJ; Erickson JD
    Am J Med Genet; 1997 Dec; 73(3):251-8. PubMed ID: 9415679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital malformations surveillance: two American systems.
    Edmonds LD; Layde PM; James LM; Flynt JW; Erickson JD; Oakley GP
    Int J Epidemiol; 1981 Sep; 10(3):247-52. PubMed ID: 7287285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of teratogenic risk: the contribution of abnormalities registries].
    De Wals P
    Rev Epidemiol Sante Publique; 1994; 42(5):392-8. PubMed ID: 7972998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth defects monitoring.
    Klingberg MA; Papier CM; Hart J
    Am J Ind Med; 1983; 4(1-2):309-28. PubMed ID: 6132552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of birth defects: lessons from history.
    Lancaster PA
    Congenit Anom (Kyoto); 2011 Mar; 51(1):2-5. PubMed ID: 21158952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil.
    Sales Luiz Vianna F; de Oliveira MZ; Sanseverino MT; Morelo EF; de Lyra Rabello Neto D; Lopez-Camelo J; Camey SA; Schuler-Faccini L
    Reprod Toxicol; 2015 Jun; 53():63-7. PubMed ID: 25828060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Registries of malformations in the Rhône-Alps/Auvergne region. Value and limits of monitoring teratogenesis. 11 years' experience (1976-1986)].
    Robert E; Francannet C; Robert JM
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(5):601-7. PubMed ID: 3230269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the measurement and interpretation of birth defect associations in epidemiologic studies.
    Khoury MJ; James LM; Erickson JD
    Am J Med Genet; 1990 Oct; 37(2):229-36. PubMed ID: 2248290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.